申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US10457674B2
公开(公告)日:2019-10-29
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I):
and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3-kinase activity.
本发明涉及某些新型化合物。具体而言,本发明涉及式(I)化合物:
及其盐类。本发明的化合物是激酶活性抑制剂,特别是 PI3 激酶活性抑制剂。